NDC 63323-400-41 - Levetiracetam
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 63323-400
- Requested NDC
- 63323-400-41
- Package NDCs from labels
- 63323-400-41, 63323-400-44, 63323-400-01, 63323-400-05
- Manufacturer
- Fresenius Kabi USA, LLC
- Effective date
- 2022-02-28
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Levetiracetam - Fresenius Kabi USA, LLC | Fresenius Kabi USA, LLC | 2022-02-28 | HUMAN PRESCRIPTION DRUG LABEL |
| Levetiracetam - Fresenius Kabi USA, LLC | Fresenius Kabi USA, LLC | 2022-01-24 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 63323-400-41 | Levetiracetam | 5 mL in 1 VIAL, SINGLE-USE | INJECTION, SOLUTION | 5 | 7 | |
| 63323-400-44 | Levetiracetam | 10 in 1 TRAY | INJECTION, SOLUTION | 10 | 7 | |
| 63323-400-01 | Levetiracetam | 5 mL in 1 VIAL, SINGLE-USE | INJECTION, SOLUTION | 5 | 6 | |
| 63323-400-05 | Levetiracetam | 10 in 1 TRAY | INJECTION, SOLUTION | 10 | 6 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 63323-400 | LEVETIRACETAM INJECTION, SOLUTION [FRESENIUS KABI USA, LLC ] | 7 | Current NDC, Legacy NDC, 2 package rows | 20220323_cc4a06f1-6509-4650-b20c-259a39353733.zip |
| 63323-400 | LEVETIRACETAM INJECTION, SOLUTION [FRESENIUS KABI USA, LLC] | 6 | Current NDC, Legacy NDC, 2 package rows | 20220222_cc41696c-9cf0-4410-bacc-09132ee805ce.zip |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 63323-400-01 | ML - Milliliter | 63323-400 | cbb8ceee-dd53-43c2-9499-b805bdf960f7 | 1 | 2023-09-05 |
| 63323-400-05 | ML - Milliliter | 63323-400 | 239be9d6-dfd7-4306-87fb-c0753bd4b55f | 1 | 2015-12-02 |
| 63323-400-09 | ML - Milliliter | 63323-400 | 6a3eead4-fa02-45c6-a9d4-dc0d8bb27acd | 1 | 2013-08-02 |
| 63323-400-41 | ML - Milliliter | 63323-400 | c3810bb2-5abe-4c4a-a784-ba543e1de2d5 | 1 | 2019-06-19 |
| 63323-400-44 | ML - Milliliter | 63323-400 | e3a18f89-b046-48aa-88da-10ca5765786c | 1 | 2019-06-19 |
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|---|---|---|---|---|
| LEVETIRACETAM | ACTIVE INGREDIENT | 44YRR34555 | LEVETIRACETAM INJECTION, SOLUTION [FRESENIUS KABI USA, LLC] | 3 | |
| LEVETIRACETAM | ACTIVE MOIETY | 44YRR34555 | LEVETIRACETAM INJECTION, SOLUTION [FRESENIUS KABI USA, LLC] | 3 | |
| ACETIC ACID | INACTIVE INGREDIENT | Q40Q9N063P | LEVETIRACETAM INJECTION, SOLUTION [FRESENIUS KABI USA, LLC] | 3 | |
| SODIUM ACETATE | INACTIVE INGREDIENT | 4550K0SC9B | LEVETIRACETAM INJECTION, SOLUTION [FRESENIUS KABI USA, LLC] | 3 | |
| SODIUM CHLORIDE | INACTIVE INGREDIENT | 451W47IQ8X | LEVETIRACETAM INJECTION, SOLUTION [FRESENIUS KABI USA, LLC] | 3 | |
| WATER | INACTIVE INGREDIENT | 059QF0KO0R | LEVETIRACETAM INJECTION, SOLUTION [FRESENIUS KABI USA, LLC] | 3 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Levetiracetam | LEVETIRACETAM | Cardinal Health 107, LLC | f924d55d-d7ec-4448-b54e-3a7eaf5a1cab | 2026-06-04 | Warnings, Adverse reactions | 44YRR34555 |
| BM Nat Mur Icing Sugar | NATRUM MURIATICUM ICING SUGAR | Total Operations Management LLC DBA:Bestmade Natural Products Micro | 5356d350-1325-7299-e063-6294a90a96a0 | 2026-06-03 | Warnings | 451W47IQ8X |
| Levetiracetam | LEVETIRACETAM | REMEDYREPACK INC. | c12d8af3-39a8-4690-8d47-43dec70b7579 | 2026-06-01 | Warnings, Adverse reactions | 44YRR34555 |
| Levetiracetam | LEVETIRACETAM | Injecta Medcial LLC | 52fa0eec-3dd9-59ca-e063-6394a90a9791 | 2026-05-29 | Warnings, Adverse reactions | 44YRR34555 |
| Plegisol | POTASSIUM CHLORIDE, SODIUM CHLORIDE, CALCIUM CHLORIDE, AND MAGNESIUM CHLORIDE | Hospira, Inc. | 35a174f0-f0d7-4ec7-3f81-d3d572c059cf | 2026-05-27 | Warnings, Adverse reactions | 451W47IQ8X |
| TPN Electrolytes | SODIUM CHLORIDE, CALCIUM CHLORIDE, POTASSIUM CHLORIDE, MAGNESIUM CHLORIDE, AND SODIUM ACETATE ANHYDROUS | Hospira, Inc. | c00817bc-7b62-4abe-0280-e7930eda3f94 | 2026-05-25 | Warnings, Adverse reactions | 451W47IQ8X |
| Bacteriostatic Water | BACTERIOSTATIC WATER | Hospira, Inc. | 87d6e9dc-fe3b-4593-ac9a-d7493d1959c7 | 2026-05-22 | Warnings, Adverse reactions | 059QF0KO0R |
| SALINE CLEANING | SODIUM CHLORIDE | Guangzhou Huanmei Cosmetics Co., Ltd. | 524f07cc-ddb9-dda5-e063-6394a90ac0a5 | 2026-05-21 | Warnings | 451W47IQ8X |
| WHITENING SUNSCREENANTI WRINKLE | WHITENING SUNSCREENANTI WRINKLE | Shantou Oushiya Biotechnology Co.,Ltd | 524384e9-b3f8-4c13-e063-6394a90a8973 | 2026-05-20 | Warnings | 059QF0KO0R |
| Sodium Chloride | SODIUM CHLORIDE | Hospira, Inc. | a2a964f7-c3ec-4dfb-e3a0-6d8136a80397 | 2026-05-19 | Warnings, Adverse reactions | 451W47IQ8X |
| Levetiracetam | LEVETIRACETAM | Preferred Pharmaceuticals, Inc. | 419b3dba-ae21-4268-ac8b-342aaa609554 | 2026-05-18 | Warnings, Adverse reactions | 44YRR34555 |
| Levetiracetam | LEVETIRACETAM | Bryant Ranch Prepack | c4a3018a-3cd8-4e07-a840-099ceae01c91 | 2026-05-15 | Warnings, Adverse reactions | 44YRR34555 |
| Herplex | ANATHERUM MURICATUM, CLEMATIS ERECTA, MEZEREUM, PHYTOLACCA DECANDRA, RANUNCULUS BULBOSUS, RHUS TOX, THUJA OCCIDENTALIS, NATRUM MURIATICUM, SEPIA | Nashco Products LLC | e5e7aa2f-3697-4747-9045-670ea2b13557 | 2026-05-14 | Warnings | 451W47IQ8X |
| Levetiracetam | LEVETIRACETAM | Coupler LLC | 51b66893-f7d6-8f9d-e063-6294a90a8e9b | 2026-05-13 | Warnings, Adverse reactions | 44YRR34555 |
| Levetiracetam | LEVETIRACETAM | Lupin Pharmaceuticals, Inc. | df661166-325d-4071-9bc1-f7bf992996d2 | 2026-05-11 | Warnings, Adverse reactions | 44YRR34555 |
| NebuClear MD | SALINE | Blue Echo Care LLC | 3f85fe62-230f-b0f1-e063-6394a90a5cb8 | 2026-05-11 | Warnings | 451W47IQ8X |
| Sterile Water | STERILE WATER | Nephron Pharmaceuticals Corporation | bc04a883-babc-87a6-e053-2995a90a3dfd | 2026-05-08 | Warnings, Adverse reactions | 059QF0KO0R |
| Acne Relief | BELLADONNA, SILICEA, GRAPHITES, HEPAR SULPHURIS CALCAREUM, KALI BROMATUM, LEDUM PALUSTRE, NATRUM MURIATICUM, SELENIUM, SULPHUR | NaturalCare | 487b1373-b78c-4510-964a-6ab0fe781ff4 | 2026-05-08 | Warnings | 451W47IQ8X |
| Migraine Relief | BELLADONNA, BRYONIA (ALBA), CHAMOMILLA, CIMICIFUGA RACEMOSA, COFFEA CRUDA, GLONOINUM, IRIS VERSICOLOR, NATRUM MURIATICUM, PASSIFLORA INCARNATA, VALERIANA OFFICINALIS | The Magni Company | 79b25c52-e145-4ee5-af2e-1ccf6ad5ac2d | 2026-05-07 | Warnings | 451W47IQ8X |
| Levetiracetam | LEVETIRACETAM | ASCLEMED USA INC. | a3c57d82-511c-4c7d-84ff-f791f931f576 | 2026-05-07 | Warnings, Adverse reactions | 44YRR34555 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.